{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:15Z","timestamp":1787022075136,"version":"build-2736575974"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Young Scientists Fund of the National Natural Science Foundation of China","award":["81803994"],"award-info":[{"award-number":["81803994"]}]},{"name":"General Program of National Natural Science Foundation of China","award":["81774284"],"award-info":[{"award-number":["81774284"]}]},{"name":"International Cooperation Project of Sichuan Science and Technology Department","award":["2019YFH0152"],"award-info":[{"award-number":["2019YFH0152"]}]},{"name":"Science and Technology Developmental Foundation of Chengdu University of TCM","award":["QNXZ2019022"],"award-info":[{"award-number":["QNXZ2019022"]}]},{"name":"General Program of National Natural Science Foundation of China","award":["82074298"],"award-info":[{"award-number":["82074298"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron metabolism is essential because it plays regulatory roles in various physiological and pathological processes. Disorders of iron metabolism balance are related to various cancers, including hepatocellular carcinoma. Cancer stem-like cells (CSCs) exert critical effects on chemotherapy failure, cancer metastasis, and subsequent disease recurrence and relapse. However, little is known about how iron metabolism affects liver CSCs. Here, we investigated the expression of transferrin receptor 1 (TFR1) and ferroportin (FPN), two iron importers, and an upstream regulator, iron regulatory protein 2 (IRP2), in liver hepatocellular carcinoma (LIHC) and related CSCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression levels of TFR1, FPN and IRP2 were analysed using the GEPIA database. CSCs were derived from parental LIHC cells cultured in serum-free medium. After TFR1 knockdown, ROS accumulation and malignant behaviours were measured. The CCK-8 assay was performed to detect cell viability after TFR1 knockdown and erastin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TFR1 expression was upregulated in LIHC tissue and CSCs derived from LIHC cell lines, prompting us to investigate the roles of TFR1 in regulating CSCs. Knockdown of TFR1 expression decreased iron accumulation and inhibited malignant behaviour. Knockdown of TFR1 expression decreased reactive oxygen species (ROS) accumulation induced by erastin treatment and maintained mitochondrial function, indicating that TFR1 is critical in regulating erastin-induced cell death in CSCs. Additionally, knockdown of TFR1 expression decreased sphere formation by decreasing iron accumulation in CSCs, indicating a potential role for TFR1 in maintaining stemness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings, which revealed TFR1 as a critical regulator of LIHC CSCs in malignant behaviour and stemness that functions by regulating iron accumulation, may have implications to improve therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0243812","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T13:32:13Z","timestamp":1608643933000},"page":"e0243812","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation"],"prefix":"10.1371","volume":"15","author":[{"given":"Chong","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-5197","authenticated-orcid":true,"given":"Ziyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"pone.0243812.ref001","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2014biological and translational implications","volume":"11","author":"SB Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"pone.0243812.ref002","article-title":"Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies","volume":"9","author":"YC Liu","year":"2020","journal-title":"Cells"},{"key":"pone.0243812.ref003","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/ijc.24868","article-title":"Cancer stem\/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma","volume":"126","author":"Z Zhu","year":"2010","journal-title":"Int J Cancer"},{"key":"pone.0243812.ref004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5009\/gnl.2012.6.1.29","article-title":"The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma","volume":"6","author":"SK Yoon","year":"2012","journal-title":"Gut Liver"},{"key":"pone.0243812.ref005","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.3390\/nu5082836","article-title":"Iron deprivation in cancer\u2014potential therapeutic implications","volume":"5","author":"JL Heath","year":"2013","journal-title":"Nutrients"},{"key":"pone.0243812.ref006","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"SV Torti","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"pone.0243812.ref007","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1615\/CritRevOncog.2013007759","article-title":"Iron and hepatic carcinogenesis","volume":"18","author":"JE Tirnitz-Parker","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"pone.0243812.ref008","doi-asserted-by":"crossref","first-page":"17667","DOI":"10.1038\/s41598-017-17804-1","article-title":"Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells","volume":"7","author":"C Raggi","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0243812.ref009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/7727","article-title":"Transferrin receptor is necessary for development of erythrocytes and the nervous system","volume":"21","author":"JE Levy","year":"1999","journal-title":"Nat Genet"},{"key":"pone.0243812.ref010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"MW Hentze","year":"2004","journal-title":"Cell"},{"key":"pone.0243812.ref011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2016.02.023","article-title":"Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation","volume":"471","author":"SM Jeong","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"pone.0243812.ref012","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-015-3554-5","article-title":"Candidate early detection protein biomarkers for ER+\/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study","volume":"153","author":"MF Buas","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0243812.ref013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jhep.2008.09.011","article-title":"Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis","volume":"50","author":"P Sorrentino","year":"2009","journal-title":"J Hepatol"},{"key":"pone.0243812.ref014","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.18632\/oncotarget.6004","article-title":"MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis","volume":"7","author":"I Kindrat","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0243812.ref015","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Z Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0243812.ref016","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.ejca.2012.03.019","article-title":"Stem cells in breast tumours: are they ready for the clinic?","volume":"48","author":"MP Ablett","year":"2012","journal-title":"Eur J Cancer"},{"key":"pone.0243812.ref017","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/onc.2016.293","article-title":"Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells","volume":"36","author":"K Tominaga","year":"2017","journal-title":"Oncogene"},{"key":"pone.0243812.ref018","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","article-title":"Identification and characterization of tumorigenic liver cancer stem\/progenitor cells","volume":"132","author":"S Ma","year":"2007","journal-title":"Gastroenterology"},{"key":"pone.0243812.ref019","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.stem.2010.11.010","article-title":"miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1","volume":"7","author":"S Ma","year":"2010","journal-title":"Cell Stem Cell"},{"key":"pone.0243812.ref020","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ccell.2018.05.003","article-title":"Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling","volume":"33","author":"D Dhar","year":"2018","journal-title":"Cancer Cell"},{"key":"pone.0243812.ref021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.stem.2011.06.005","article-title":"CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation","volume":"9","author":"TK Lee","year":"2011","journal-title":"Cell Stem Cell"},{"key":"pone.0243812.ref022","doi-asserted-by":"crossref","first-page":"e166593","DOI":"10.1371\/journal.pone.0166593","article-title":"Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas","volume":"11","author":"C Weston","year":"2016","journal-title":"PLoS One"},{"key":"pone.0243812.ref023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12032-009-9203-2","article-title":"Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer","volume":"27","author":"S Kukulj","year":"2010","journal-title":"Med Oncol"},{"key":"pone.0243812.ref024","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cgt.2013.9","article-title":"Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy","volume":"20","author":"ER Camp","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"pone.0243812.ref025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jinorgbio.2016.04.014","article-title":"Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-alpha-dependent NF-kappaB signaling and TGF-beta signaling","volume":"160","author":"P Liu","year":"2016","journal-title":"J Inorg Biochem"},{"key":"pone.0243812.ref026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and Iron: current questions","volume":"10","author":"BT Paul","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"pone.0243812.ref027","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"82\u201383","author":"CC Winterbourn","year":"1995","journal-title":"Toxicol Lett"},{"key":"pone.0243812.ref028","doi-asserted-by":"crossref","first-page":"C728","DOI":"10.1152\/ajpcell.00322.2015","article-title":"Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells","volume":"310","author":"P Chanvorachote","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"pone.0243812.ref029","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.copbio.2007.10.007","article-title":"Cancer stem cells in solid tumors","volume":"18","author":"LE Ailles","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"pone.0243812.ref030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"DF Quail","year":"2013","journal-title":"Nat Med"},{"key":"pone.0243812.ref031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cellsig.2014.11.002","article-title":"Disordered signaling governing ferroportin transcription favors breast cancer growth","volume":"27","author":"Y Chen","year":"2015","journal-title":"Cell Signal"},{"key":"pone.0243812.ref032","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-14-2465","article-title":"Hepcidin regulation in prostate and its disruption in prostate cancer","volume":"75","author":"L Tesfay","year":"2015","journal-title":"Cancer Res"},{"key":"pone.0243812.ref033","doi-asserted-by":"crossref","first-page":"62019","DOI":"10.18632\/oncotarget.11495","article-title":"Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition","volume":"7","author":"N Lobello","year":"2016","journal-title":"Oncotarget"},{"key":"pone.0243812.ref034","doi-asserted-by":"crossref","first-page":"43r","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"ZK Pinnix","year":"2010","journal-title":"Sci Transl Med"},{"key":"pone.0243812.ref035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: Death by Lipid Peroxidation","volume":"26","author":"WS Yang","year":"2016","journal-title":"Trends Cell Biol"},{"key":"pone.0243812.ref036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"MW Hentze","year":"2010","journal-title":"Cell"},{"key":"pone.0243812.ref037","first-page":"8578","article-title":"Differential expression of manganese superoxide dismutase and catalase in lung cancer","volume":"61","author":"HJ Chung-man","year":"2001","journal-title":"Cancer Res"},{"key":"pone.0243812.ref038","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-11-3633","article-title":"SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis","volume":"72","author":"MC Haigis","year":"2012","journal-title":"Cancer Res"},{"key":"pone.0243812.ref039","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"MM Ho","year":"2007","journal-title":"Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T07:30:57Z","timestamp":1698478257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243812"}},"subtitle":[],"editor":[{"given":"Gianpaolo","family":"Papaccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243812","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,22]]}}}